A similar panel study of 57 men with CAD showed central-site ultrafine PN concentrations in Erfurt, Germany, was positively associated with soluble CD40 ligand, another marker of platelet activation (Rückerl et al. 2007b). This evidence concerns the gene CD40LG and coronary artery disorder.